Lennert Veerman

49.0k total citations · 2 hit papers
151 papers, 6.0k citations indexed

About

Lennert Veerman is a scholar working on Public Health, Environmental and Occupational Health, Organizational Behavior and Human Resource Management and Economics and Econometrics. According to data from OpenAlex, Lennert Veerman has authored 151 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Public Health, Environmental and Occupational Health, 38 papers in Organizational Behavior and Human Resource Management and 29 papers in Economics and Econometrics. Recurrent topics in Lennert Veerman's work include Obesity, Physical Activity, Diet (54 papers), Global Public Health Policies and Epidemiology (38 papers) and Health Systems, Economic Evaluations, Quality of Life (24 papers). Lennert Veerman is often cited by papers focused on Obesity, Physical Activity, Diet (54 papers), Global Public Health Policies and Epidemiology (38 papers) and Health Systems, Economic Evaluations, Quality of Life (24 papers). Lennert Veerman collaborates with scholars based in Australia, United States and Netherlands. Lennert Veerman's co-authors include Theo Vos, Jan J. Barendregt, Sarah J. Blondell, Rachel Hammersley‐Mather, Linda Cobiac, Gary Sacks, Karen Hofman, Marj Moodie, Johan P. Mackenbach and Melanie Bertram and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Lennert Veerman

147 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013

2016 841 citations Hmwe Hmwe Kyu, Lily Alexander et al. BMJ profile →
Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies

2014 620 citations Lennert Veerman et al. BMC Public Health profile →

Peers

Countries citing papers authored by Lennert Veerman

Since Specialization

Citations

This map shows the geographic impact of Lennert Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lennert Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lennert Veerman more than expected).

Fields of papers citing papers by Lennert Veerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lennert Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lennert Veerman. The network helps show where Lennert Veerman may publish in the future.

Co-authorship network of co-authors of Lennert Veerman

This figure shows the co-authorship network connecting the top 25 collaborators of Lennert Veerman. A scholar is included among the top collaborators of Lennert Veerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lennert Veerman. Lennert Veerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of tobacco advertising, promotion and sponsorship bans on smoking prevalence, initiation and cessation: a systematic review and meta-analysis 2025 ·Tobacco Control ·(unknown), (unknown), (unknown), Abhishek Thakur, (unknown), Lai K. Leung, Lennert Veerman, Léopold Ndemnge Aminde	3
2	Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans-fatty acids in Nigeria: cost-effectiveness analysis 2024 ·BMJ Global Health ·Matti Marklund, Léopold Ndemnge Aminde, Mary Njeri Wanjau, Boni Maxime Ale, (unknown), (unknown), (unknown), Liping Huang, Lennert Veerman, Jason Wu, Mark D. Huffman, Dike Ojji	1
3	Physical activity and life expectancy: a life-table analysis 2024 ·British Journal of Sports Medicine ·Lennert Veerman, Jakob Tarp, (unknown), Mary Njeri Wanjau, Holger Möller, Fiona Haigh, (unknown), Andrew Milat	2
4	Cost-effectiveness analysis of low-sodium potassium-rich salt substitutes in Indonesia: an equity modelling study 2024 ·The Lancet Regional Health - Southeast Asia ·Léopold Ndemnge Aminde, (unknown), Rofingatul Mubasyiroh, (unknown), Febi Dwirahmadi, Santi Martini, Nunik Kusumawardani, Lennert Veerman	1
5	Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis 2023 ·BMJ Global Health ·Matti Marklund, Léopold Ndemnge Aminde, Mary Njeri Wanjau, Liping Huang, (unknown), (unknown), Laura K. Cobb, Lennert Veerman, Jason Wu	3
6	Does active transport displace other physical activity? A systematic review of the evidence 2023 ·Journal of Transport & Health ·Mary Njeri Wanjau, (unknown), (unknown), Holger Jon Møller, Christopher Standen, Fiona Haigh, Andrew Milat, (unknown), Lennert Veerman	13
7	A cost–benefit analysis framework for preventive health interventions to aid decision-making in Australian governments 2021 ·Health Research Policy and Systems ·Jaithri Ananthapavan, Marj Moodie, Andrew Milat, Lennert Veerman, Elizabeth Whittaker, Rob Carter	12
8	Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study 2020 ·PLoS Medicine ·Matti Marklund, Miaobing Zheng, Lennert Veerman, Jason Wu	18
9	Health promotion at the workplace setting: a protocol for a systematic review of effectiveness and sustainability of current practice in low-income and middle-income countries 2019 ·BMJ Open ·Mary Njeri Wanjau, Belén Zapata-Diomedi, Lennert Veerman	1
10	Economic costs of informal care for people with chronic diseases in the community: Lost income, extra welfare payments, and reduced taxes in Australia in 2015-2030 2018 ·Health & Social Care in the Community ·Deborah Schofield, Rupendra Shrestha, Melanie Zeppel, Michelle Cunich, Robert Tanton, Lennert Veerman, Simon Kelly, Megan Passey	24
11	The costs of diabetes among Australians aged 45–64 years from 2015 to 2030: projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD2030 2017 ·BMJ Open ·Deborah Schofield, Rupendra Shrestha, Michelle Cunich, Megan Passey, Lennert Veerman, Robert Tanton, Simon Kelly	19
12	Economic costs of chronic disease through lost productive life years (PLYs) among Australians aged 45–64 years from 2015 to 2030: results from a microsimulation model 2016 ·BMJ Open ·Deborah Schofield, Rupendra Shrestha, Michelle Cunich, Robert Tanton, Lennert Veerman, Simon Kelly, Megan Passey	14
13	Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013 breakdown → 2016 ·BMJ ·Hmwe Hmwe Kyu, (unknown), Lily Alexander, John Everett Mumford, Ashkan Afshin, Kara Estep, Lennert Veerman, (unknown), Marissa Iannarone, (unknown), Kelly Cercy, Theo Vos, Christopher J L Murray, Mohammad H. Forouzanfar	841
14	Cost-Effectiveness Study of HPV Vaccination as a Primary Prevention Strategy for Anal Cancer in HIV-Positive Men in Chile 2016 ·Value in Health Regional Issues ·(unknown), Lennert Veerman	4
15	Cost-effectiveness of investing in sidewalks as a means of increasing physical activity: a RESIDE modelling study 2016 ·BMJ Open ·Lennert Veerman, Belén Zapata-Diomedi, Lucy Gunn, Gavin R. McCormack, Linda Cobiac, Ana Maria Mantilla Herrera, Billie Giles‐Corti, Alan Shiell	23
16	Pharmacy workforce to prevent and manage non-communicable diseases in developing nations: The case of Nepal 2015 ·Research in Social and Administrative Pharmacy ·Saval Khanal, Lisa Nissen, Lennert Veerman, Samantha Hollingworth	10
17	Evidence that a tax on sugar sweetened beverages reduces the obesity rate: a meta-analysis 2013 ·BMC Public Health ·(unknown), Lennert Veerman, Stephen Tollman, Melanie Bertram, Karen Hofman	250
18	Use of a quality assessment tool for a systematic review on osteoporosis prevalence 2010 ·Queensland's institutional digital repository (The University of Queensland) ·(unknown), Nick Wilson, Damian Hoy, Richard Norman, Lennert Veerman, (unknown), Anthony D. Woolf, Theo Vos, Lyn March, (unknown)	2
19	By how much would limiting TV food advertising reduce childhood obesity? 2009 ·European Journal of Public Health ·Lennert Veerman, Ed F. van Beeck, Jan J. Barendregt, Johan P. Mackenbach	127
20	Validity of predictions in health impact assessment: Figure 1 2007 ·Journal of Epidemiology & Community Health ·Lennert Veerman, Johan P. Mackenbach, Jan J. Barendregt	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact